| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/16/2011 | CN101357953B Preparation method of sulfated polysaccharides |
| 02/16/2011 | CN101249158B Traditional Chinese medicine preparation for preventing and treating cardiovascular and cerebrovascular diseases and preparation |
| 02/16/2011 | CN101228936B Low calorific value bean paste and preparing method thereof |
| 02/16/2011 | CN101139280B Preparation method of sodium acetate anhydrous |
| 02/16/2011 | CN101028320B Vegetable medicinal composition with hypoglycemic and hypolipidemic functions and its making method |
| 02/15/2011 | US7888510 1,4-disubstituted piperidine compounds like N-(9-Ethyl-9H-carbazol-3-yl)-2-[4-(2-hydroxymethyl-6-methyl-phenylamino)-piperidine-yl]acetamide; chloroacetyl chloride is reacted with respective compounds in the presence of dichloromethane and triethylamine or diisopropylethylamine |
| 02/15/2011 | US7888504 Glucokinase activators and methods of using same |
| 02/15/2011 | US7888487 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 02/15/2011 | US7888458 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 02/15/2011 | US7888388 Peroxisome proliferator activated receptor ligand and process for producing the same |
| 02/15/2011 | US7888343 Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase |
| 02/15/2011 | US7888089 Nucleotide sequences coding polypeptide for use in the treatment of cardivascular, restenosis, hypertension, atherosclerosis, heart defects, diabetes and neovascularization disorders; endothelial nitric oxide synthase (eNOS) |
| 02/15/2011 | US7888056 Method of forming a peptide-receptor complex with zsig33 |
| 02/15/2011 | US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887795 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 02/15/2011 | CA2689052C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/15/2011 | CA2615271C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2529452C Serum cholesterol lowering agent or preventive or therapeutic agent for atherosclerosis |
| 02/15/2011 | CA2496842C Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/15/2011 | CA2481460C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 02/15/2011 | CA2480872C Amino acids with affinity for the .alpha.-2-.delta.-protein |
| 02/15/2011 | CA2480562C 5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2470067C Imidazoquinoline derivatives |
| 02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
| 02/15/2011 | CA2446864C Inhibitors of src and other protein kinases |
| 02/15/2011 | CA2407046C Immunoregulator |
| 02/15/2011 | CA2407027C Improved water-insoluble drug particle process |
| 02/15/2011 | CA2406930C Preparation of aqueous clear solution dosage forms with bile acids |
| 02/15/2011 | CA2356701C Gene therapy for diabetic ischemic disease |
| 02/15/2011 | CA2247420C Combination therapy for osteoporosis |
| 02/13/2011 | CA2804265A1 Methods and compositions for treating thyroid-related medical conditions with reduced folates |
| 02/10/2011 | WO2011017554A2 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 02/10/2011 | WO2011017516A2 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
| 02/10/2011 | WO2011017488A2 Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity |
| 02/10/2011 | WO2011017054A2 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 02/10/2011 | WO2011016558A1 Method for producing glucosylceramide-containing material |
| 02/10/2011 | WO2011016501A1 Prophylactic or therapeutic agent for cancer |
| 02/10/2011 | WO2011016470A1 Sulfone derivative |
| 02/10/2011 | WO2011016469A1 Amide derivative |
| 02/10/2011 | WO2011016459A1 Thienooxazepine derivative |
| 02/10/2011 | WO2011016220A1 Dipeptidyl peptidase-4 inhibitor |
| 02/10/2011 | WO2011015668A1 Use of cajeput and pimenta racemosa extract for treating parasitic infestation of fish |
| 02/10/2011 | WO2011015629A1 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors |
| 02/10/2011 | WO2010008776A9 Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
| 02/10/2011 | US20110035817 Siva 3, its preparation and use |
| 02/10/2011 | US20110034685 Method for Purification of Lactose |
| 02/10/2011 | US20110034560 Liquid formulations of compounds active at sulfonylurea receptors |
| 02/10/2011 | US20110034555 Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
| 02/10/2011 | US20110034548 Method for Suspending a Flavonoid in a Beverage |
| 02/10/2011 | US20110034542 Novel synthetic analogs of sphingolipids |
| 02/10/2011 | US20110034533 Compositions and methods modulating mg29 for the treatment of diabetes |
| 02/10/2011 | US20110034527 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 02/10/2011 | US20110034526 Benzimidazole Compounds |
| 02/10/2011 | US20110034524 Hemi-fumarate salt of a 1,3,4-thiadiazolyl derivative as modulator of the sphingosine 1-phosphate receptor |
| 02/10/2011 | US20110034522 Methods for alleviating deleterious effects of 3-deoxyglucosone |
| 02/10/2011 | US20110034520 Inhibitors of P38 Map Kinase |
| 02/10/2011 | US20110034518 Pharmaceutical composition |
| 02/10/2011 | US20110034517 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 02/10/2011 | US20110034512 Indazole Compounds As CCR1 Receptor Antagonists |
| 02/10/2011 | US20110034507 Farnesoid x receptor agonists |
| 02/10/2011 | US20110034506 Triazolopyridine compounds useful as dgat1 inhibitors |
| 02/10/2011 | US20110034505 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators |
| 02/10/2011 | US20110034501 Method of restoring the incretin effect |
| 02/10/2011 | US20110034499 Spiroindolines as modulators of chemokine receptors |
| 02/10/2011 | US20110034497 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/10/2011 | US20110034495 Method of Modulating Stress-Activated Protein Kinase System |
| 02/10/2011 | US20110034487 Cxcr3 antagonists |
| 02/10/2011 | US20110034484 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
| 02/10/2011 | US20110034481 Novel tetrahydroisoquinoline derivative |
| 02/10/2011 | US20110034479 Deuterium-enriched alkyl sulfonamides |
| 02/10/2011 | US20110034472 Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function |
| 02/10/2011 | US20110034470 Inhibitors of JNK |
| 02/10/2011 | US20110034468 Triazolo compounds useful as dgat1 inhibitors |
| 02/10/2011 | US20110034462 Organic compounds |
| 02/10/2011 | US20110034461 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034456 Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034455 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 02/10/2011 | US20110034452 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034451 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034450 Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof |
| 02/10/2011 | US20110034444 Selected cgrp antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 02/10/2011 | US20110034443 Uses of substituted imidazoheterocycles |
| 02/10/2011 | US20110034441 Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof |
| 02/10/2011 | US20110034437 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/10/2011 | US20110034436 spirocyclic aminoquinolnes as gsk-3 inhibitors |
| 02/10/2011 | US20110034432 Benzamide derivatives and their use as glucokinase activating agents |
| 02/10/2011 | US20110034407 Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota |
| 02/10/2011 | US20110034402 C-aryl glycoside compounds for the treatment of diabetes and obesity |
| 02/10/2011 | US20110034380 Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity |
| 02/10/2011 | US20110034379 Gastrin Compositions And Formulations, And Methods Of Use And Preparation |
| 02/10/2011 | US20110034378 Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc. |
| 02/10/2011 | US20110034377 Exendin and Exendin Agonists for Eating Disorders |
| 02/10/2011 | US20110034375 Non-basic melanin concentrating hormone receptor-1 antagonists |
| 02/10/2011 | US20110034374 Oxyntomodulin for Preventing or Treating Excess Weight |
| 02/10/2011 | US20110034373 Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity |
| 02/10/2011 | US20110034372 Truncated activin type ii receptor and methods of use |
| 02/10/2011 | US20110033561 Use of phytoecdysones in the preparation of a composition for acting on the metabolic syndrome |